Vimarsana
Biggest News Aggregation in the World

Page 9 - Ioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ioscience Today - Breaking & Trending Today

Lexaria Bioscience Corp.: Lexaria Discovers that DehydraTECH-CBD Treatment in Hypertension Study HYPER-H21-4 Resulted in Reduction in Pro-Inflammatory Biomarkers - Vimarsana News

Lexaria Bioscience Corp.: Lexaria Discovers that DehydraTECH-CBD Treatment in Hypertension Study HYPER-H21-4 Resulted in Reduction in Pro-Inflammatory Biomarkers

DehydraTECH-CBD offers distinctive mechanistic benefits related to its growing therapeutic utilityKELOWNA, BC / ACCESSWIRE / May 23, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company"

Lexaria Discovers that DehydraTECH-CBD Treatment in Hypertension Study HYPER-H21-4 Resulted in Reduction in Pro-Inflammatory Biomarkers - Vimarsana News

Lexaria Discovers that DehydraTECH-CBD Treatment in Hypertension Study HYPER-H21-4 Resulted in Reduction in Pro-Inflammatory Biomarkers

DehydraTECH-CBD offers distinctive mechanistic benefits related to its growing therapeutic utility  Kelowna, BC - TheNewswire - May 23, 2023 - Lexaria Bioscience Corp. , a global innovator... | May 23, 2023

Arix Bioscience PLC: Result of Annual General Meeting - Vimarsana News

Arix Bioscience PLC: Result of Annual General Meeting

DJ Result of Annual General Meeting Arix Bioscience PLC (ARIX) Result of Annual General Meeting 23-May-2023 / 16:30 GMT/BST -----------------------------------------------------------------------------------------------------------------------

Lexaria Bioscience Corp.: Lexaria's Hormone Study Shows Significant Enhancement in Oral Estradiol Delivery - Vimarsana News

Lexaria Bioscience Corp.: Lexaria's Hormone Study Shows Significant Enhancement in Oral Estradiol Delivery

900% and 2,000% improvements in peak bloodstream delivery using DehydraTECHKELOWNA, BC / ACCESSWIRE / May 18, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a

Satellos Bioscience Inc.: Satellos Bioscience Closes $55M Financing to Support Development of its Lead Drug Candidate for Duchenne Muscular Dystrophy - Vimarsana News

Satellos Bioscience Inc.: Satellos Bioscience Closes $55M Financing to Support Development of its Lead Drug Candidate for Duchenne Muscular Dystrophy

Toronto, Ontario--(Newsfile Corp. - May 17, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the